Current:Home > ContactCommanders bench Sam Howell, will start Jacoby Brissett at QB vs. 49ers -TradeWisdom
Commanders bench Sam Howell, will start Jacoby Brissett at QB vs. 49ers
View
Date:2025-04-22 18:21:06
The starting quarterback job for the Washington Commanders no longer belongs to Sam Howell.
Jacoby Brissett will start against the NFC-leading San Francisco 49ers on Sunday, head coach Ron Rivera announced Wednesday, following two straight games in which the veteran backup has relieved the second-year starter.
Rivera wouldn't say whether that meant Brissett would start the final game of the regular season against the Dallas Cowboys. He also said that he advised ownership, which will make a decision on Rivera's own future in the coming weeks, of the decision.
"This is about Sam's continued development," Rivera said. "Things hadn't gone as well as we'd like the last few weeks, so we just think this is a good opportunity for him to watch."
The Commanders have lost a league-worst six straight games and Howell has struggled during that span with a 57.4 completion percentage and eight interceptions.
NFL STATS CENTRAL: The latest NFL scores, schedules, odds, stats and more.
Over 15 games, Howell leads the league with 18 interceptions and has been sacked 60 times. The offense moved the ball more consistently after Brissett's insertions against the Los Angeles Rams and New York Jets.
"I think this is an opportunity for (Howell) to take a breath," Rivera said.
Washington entered the season with its focus on handing the starting role to Howell, a fifth-round pick who started the final week of the 2022 season, with Brissett as the veteran option if that didn't seem viable during training camp. But Howell didn't do anything to lose the job then, and Rivera wanted to commit to the young quarterback in an effort to create a long-term plan at the position.
Brissett will be the ninth starting quarterback for the team since Rivera took over in 2020.
"I think (Howell) has a bright future in this league, I really do," Rivera said.
He added: "We're all culpable in this situation. This is not an indictment on Sam ... this has been a long year, for everybody."
veryGood! (5)
Related
- Woman dies after Singapore family of 3 gets into accident in Taiwan
- New York Rejects a Natural Gas Pipeline, and Federal Regulators Say That’s OK
- Earth’s Hottest Decade on Record Marked by Extreme Storms, Deadly Wildfires
- Ulta 24-Hour Flash Deal: Get a Salon-Level Blowout and Save 50% On the Bondi Boost Blowout Brush
- Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
- Can multivitamins improve memory? A new study shows 'intriguing' results
- Farewell, my kidney: Why the body may reject a lifesaving organ
- Vanderpump Rules Reunion Part One: Every Bombshell From the Explosive Scandoval Showdown
- North Carolina trustees approve Bill Belichick’s deal ahead of introductory news conference
- iCarly Cast Recalls Emily Ratajkowski's Hilarious Cameo
Ranking
- House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
- FDA advisers narrowly back first gene therapy for muscular dystrophy
- Niall Horan Teasing Details About One Direction’s Group Chat Is Simply Perfect
- How Boulder Taxed its Way to a Climate-Friendlier Future
- This was the average Social Security benefit in 2004, and here's what it is now
- How a little more silence in children's lives helps them grow
- As the Culture Wars Flare Amid the Pandemic, a Call to Speak ‘Science to Power’
- Tiger King star Doc Antle convicted of wildlife trafficking in Virginia
Recommendation
New data highlights 'achievement gap' for students in the US
Legendary Singer Tina Turner Dead at 83
Carrie Actress Samantha Weinstein Dead at 28 After Cancer Battle
North Carolina's governor vetoed a 12-week abortion ban, setting up an override fight
EU countries double down on a halt to Syrian asylum claims but will not yet send people back
Trump’s EPA Starts Process for Replacing Clean Power Plan
Solar Breakthrough Could Be on the Way for Renters
FDA advisers narrowly back first gene therapy for muscular dystrophy